Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. (2023)
Attributed to:
Developing Existing Healthcare Technologies to Deliver More Affordable and Effective Cancer Care
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2022.11.002
PubMed Identifier: 36494221
Publication URI: http://europepmc.org/abstract/MED/36494221
Type: Journal Article/Review
Volume: 83
Parent Publication: European urology
Issue: 3
ISSN: 0302-2838